Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xbiotech Inc. (XBIT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xbiotech Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1626878.
Total stock buying since 2015: $11,922,590.
Total stock sales since 2015: $53,350,243.
Total stock option exercises since 2015: $9,174,274.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 400,000 | $5,643,473 | 785,000 | $6,488,000 |
| 2020 | 0 | $0 | 3,486,626 | $44,711,554 | 273,833 | $1,387,183 |
| 2019 | 1,367,900 | $11,404,047 | 11,659 | $71,395 | 189,500 | $705,000 |
| 2018 | 39,102 | $218,804 | 672,841 | $2,284,312 | 130,000 | $324,999 |
| 2017 | 0 | $0 | 0 | $0 | 240,000 | $223,680 |
| 2016 | 21,500 | $299,739 | 20,000 | $300,000 | 20,000 | $14,812 |
| 2015 | 0 | $0 | 31,800 | $339,509 | 31,800 | $30,600 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-12 | 0 | $0 | 0 | $0 | 250,000 | $2,500,000 |
| 2021-10 | 0 | $0 | 207,583 | $2,673,494 | 0 | $0 |
| 2021-09 | 0 | $0 | 142,417 | $2,062,630 | 0 | $0 |
| 2021-07 | 0 | $0 | 50,000 | $907,349 | 35,000 | $238,000 |
| 2021-03 | 0 | $0 | 0 | $0 | 500,000 | $3,750,000 |
| 2020-12 | 0 | $0 | 1,355,869 | $25,397,398 | 0 | $0 |
| 2020-11 | 0 | $0 | 375,000 | $6,862,500 | 0 | $0 |
| 2020-09 | 0 | $0 | 40,000 | $800,193 | 97,692 | $542,306 |
| 2020-08 | 0 | $0 | 53,141 | $1,043,973 | 53,141 | $383,627 |
| 2020-02 | 0 | $0 | 1,662,616 | $10,607,490 | 0 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 123,000 | $461,250 |
| 2019-11 | 0 | $0 | 0 | $0 | 185,000 | $693,750 |
| 2019-09 | 0 | $0 | 7,159 | $26,395 | 0 | $0 |
| 2019-06 | 1,200,000 | $9,900,000 | 0 | $0 | 0 | $0 |
| 2019-03 | 51,425 | $414,470 | 0 | $0 | 0 | $0 |
| 2019-02 | 115,575 | $1,084,942 | 4,500 | $45,000 | 4,500 | $11,250 |
| 2019-01 | 900 | $4,635 | 0 | $0 | 0 | $0 |
| 2018-12 | 36,202 | $207,962 | 0 | $0 | 50,000 | $125,000 |
| 2018-11 | 2,900 | $10,842 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 385,000 | $1,155,000 | 0 | $0 |
| 2018-09 | 0 | $0 | 107,841 | $347,681 | 0 | $0 |
| 2018-08 | 0 | $0 | 88,125 | $350,702 | 0 | $0 |
| 2018-07 | 0 | $0 | 11,875 | $52,857 | 0 | $0 |
| 2018-03 | 0 | $0 | 80,000 | $378,072 | 80,000 | $199,999 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-16 | Mckenzie W Thorpe (Director) | Option Ex | 250,000 | 10.00 | 2,500,000 |
| 2021-10-18 | Simard John (Chief Executive Officer) | Sale | 33,000 | 13.07 | 431,244 |
| 2021-10-15 | Simard John (Chief Executive Officer) | Sale | 17,000 | 13.32 | 226,474 |
| 2021-10-14 | Simard John (Chief Executive Officer) | Sale | 21,125 | 12.90 | 272,533 |
| 2021-10-13 | Simard John (Chief Executive Officer) | Sale | 10,875 | 12.83 | 139,526 |
| 2021-10-12 | Simard John (Chief Executive Officer) | Sale | 18,000 | 12.77 | 229,931 |
| 2021-10-07 | Simard John (Chief Executive Officer) | Sale | 39,286 | 12.45 | 489,110 |
| 2021-10-06 | Simard John (Chief Executive Officer) | Sale | 10,714 | 12.53 | 134,257 |
| 2021-10-05 | Simard John (Chief Executive Officer) | Sale | 14,218 | 12.66 | 180,056 |
| 2021-10-04 | Simard John (Chief Executive Officer) | Sale | 23,681 | 13.09 | 309,865 |
| 2021-10-01 | Simard John (Chief Executive Officer) | Sale | 19,684 | 13.23 | 260,498 |
| 2021-09-30 | Simard John (Chief Executive Officer) | Sale | 18,558 | 13.06 | 242,460 |
| 2021-09-29 | Simard John (Chief Executive Officer) | Sale | 16,396 | 13.41 | 219,804 |
| 2021-09-28 | Simard John (Chief Executive Officer) | Sale | 6,263 | 14.27 | 89,366 |
| 2021-09-27 | Simard John (Chief Executive Officer) | Sale | 29,890 | 14.81 | 442,790 |
| 2021-09-24 | Simard John (Chief Executive Officer) | Sale | 11,418 | 14.49 | 165,412 |
| 2021-09-23 | Simard John (Chief Executive Officer) | Sale | 9,892 | 14.68 | 145,224 |
| 2021-09-22 | Simard John (Chief Executive Officer) | Sale | 19,669 | 15.14 | 297,749 |
| 2021-09-21 | Simard John (Chief Executive Officer) | Sale | 16,860 | 15.24 | 256,912 |
| 2021-09-20 | Simard John (Chief Executive Officer) | Sale | 13,471 | 15.06 | 202,913 |
| 2021-07-14 | Simard John (Chief Executive Officer) | Sale | 50,000 | 18.15 | 907,349 |
| 2021-07-09 | Libby Peter (Director) | Option Ex | 25,000 | 7.76 | 194,000 |
| 2021-07-09 | Macadam Donald H. (Director) | Option Ex | 10,000 | 4.40 | 44,000 |
| 2021-03-22 | Simard John (Chief Executive Officer) | Option Ex | 500,000 | 7.50 | 3,750,000 |
| 2020-12-18 | Bay Street Financial S.a. (10% Owner) | Sale | 1,173,033 | 18.78 | 22,029,559 |
| 2020-12-02 | Bay Street Financial S.a. (10% Owner) | Sale | 182,836 | 18.42 | 3,367,839 |
| 2020-11-19 | Mckenzie W Thorpe (Director) | Sale | 375,000 | 18.30 | 6,862,500 |
| 2020-09-15 | Shivaswamy Sushma (Chief Scientific Officer) | Sale | 20,668 | 20.00 | 413,360 |
| 2020-09-15 | Shivaswamy Sushma (Chief Scientific Officer) | Option Ex | 20,668 | 7.50 | 155,010 |
| 2020-09-10 | Shivaswamy Sushma (Chief Scientific Officer) | Sale | 19,332 | 20.01 | 386,833 |
| 2020-09-10 | Shivaswamy Sushma (Chief Scientific Officer) | Option Ex | 19,332 | 7.50 | 144,990 |
| 2020-09-01 | Han Queena (VP Finance & HR) | Option Ex | 57,692 | 4.20 | 242,306 |
| 2020-08-24 | Han Queena (VP Finance & HR) | Sale | 51,841 | 19.65 | 1,018,883 |
| 2020-08-24 | Han Queena (VP Finance & HR) | Option Ex | 51,841 | 7.21 | 373,877 |
| 2020-08-17 | Han Queena (VP Finance & HR) | Sale | 1,300 | 19.30 | 25,090 |
| 2020-08-17 | Han Queena (VP Finance & HR) | Option Ex | 1,300 | 7.50 | 9,750 |
| 2020-02-19 | Bay Street Financial S.a. (10% Owner) | Sale | 1,662,616 | 6.38 | 10,607,490 |
| 2020-01-06 | Mckenzie W Thorpe (Director) | Option Ex | 123,000 | 3.75 | 461,250 |
| 2019-11-29 | Mckenzie W Thorpe (Director) | Option Ex | 185,000 | 3.75 | 693,750 |
| 2019-09-06 | Mckenzie W Thorpe (Director) | Sale | 7,159 | 3.69 | 26,395 |
| 2019-06-04 | Rennes Fondation (10% Owner) | Buy | 1,200,000 | 8.25 | 9,900,000 |
| 2019-03-04 | Rennes Fondation (10% Owner) | Buy | 16,426 | 7.91 | 129,929 |
| 2019-03-01 | Rennes Fondation (10% Owner) | Buy | 34,999 | 8.13 | 284,541 |
| 2019-02-28 | Rennes Fondation (10% Owner) | Buy | 5,302 | 8.19 | 43,423 |
| 2019-02-27 | Rennes Fondation (10% Owner) | Buy | 5,273 | 8.13 | 42,869 |
| 2019-02-07 | Shivaswamy Sushma (Chief Scientific Officer) | Sale | 4,500 | 10.00 | 45,000 |
| 2019-02-07 | Shivaswamy Sushma (Chief Scientific Officer) | Option Ex | 4,500 | 2.50 | 11,250 |
| 2019-02-07 | Rennes Fondation (10% Owner) | Buy | 40,000 | 10.00 | 400,000 |
| 2019-02-06 | Rennes Fondation (10% Owner) | Buy | 65,000 | 9.21 | 598,650 |
| 2019-01-02 | Rennes Fondation (10% Owner) | Buy | 900 | 5.15 | 4,635 |
| 2018-12-27 | Mckenzie W Thorpe (Director) | Buy | 1,364 | 4.92 | 6,705 |
| 2018-12-27 | Rennes Fondation (10% Owner) | Buy | 2,200 | 4.98 | 10,956 |
| 2018-12-26 | Mckenzie W Thorpe (Director) | Buy | 3,600 | 5.00 | 17,996 |
| 2018-12-24 | Mckenzie W Thorpe (Director) | Buy | 24,838 | 5.88 | 146,097 |
| 2018-12-21 | Rennes Fondation (10% Owner) | Buy | 4,200 | 6.24 | 26,208 |
| 2018-12-19 | Simard John (Chief Executive Officer) | Option Ex | 50,000 | 2.50 | 125,000 |
| 2018-11-12 | Mckenzie W Thorpe (Director) | Buy | 700 | 3.75 | 2,625 |
| 2018-11-09 | Mckenzie W Thorpe (Director) | Buy | 2,200 | 3.73 | 8,217 |
| 2018-10-04 | Mckenzie W Thorpe (Director) | Sale | 385,000 | 3.00 | 1,155,000 |
| 2018-09-26 | Mckenzie W Thorpe (Director) | Sale | 17,634 | 3.05 | 53,801 |
| 2018-09-13 | Mckenzie W Thorpe (Director) | Sale | 7,909 | 3.10 | 24,549 |
| 2018-09-12 | Mckenzie W Thorpe (Director) | Sale | 41,675 | 3.06 | 127,567 |
| 2018-09-10 | Mckenzie W Thorpe (Director) | Sale | 23,369 | 3.22 | 75,341 |
| 2018-09-07 | Mckenzie W Thorpe (Director) | Sale | 6,234 | 3.65 | 22,760 |
| 2018-09-05 | Mckenzie W Thorpe (Director) | Sale | 7,220 | 3.94 | 28,482 |
| 2018-09-04 | Mckenzie W Thorpe (Director) | Sale | 3,800 | 4.00 | 15,181 |
| 2018-08-10 | Mckenzie W Thorpe (Director) | Sale | 3,171 | 3.98 | 12,623 |
| 2018-08-09 | Mckenzie W Thorpe (Director) | Sale | 6,638 | 4.00 | 26,525 |
| 2018-08-08 | Mckenzie W Thorpe (Director) | Sale | 4,000 | 4.01 | 16,024 |
| 2018-08-07 | Mckenzie W Thorpe (Director) | Sale | 8,452 | 3.94 | 33,334 |
| 2018-08-06 | Mckenzie W Thorpe (Director) | Sale | 3,340 | 3.99 | 13,326 |
| 2018-08-03 | Mckenzie W Thorpe (Director) | Sale | 23,900 | 3.96 | 94,691 |
| 2018-08-02 | Mckenzie W Thorpe (Director) | Sale | 30,461 | 3.92 | 119,528 |
| 2018-08-01 | Mckenzie W Thorpe (Director) | Sale | 8,163 | 4.25 | 34,651 |
| 2018-07-31 | Mckenzie W Thorpe (Director) | Sale | 6,531 | 4.49 | 29,317 |
| 2018-07-30 | Mckenzie W Thorpe (Director) | Sale | 5,344 | 4.41 | 23,540 |
| 2018-03-23 | Han Queena (VP Finance & HR) | Sale | 8,201 | 4.75 | 38,954 |
| 2018-03-23 | Han Queena (VP Finance & HR) | Option Ex | 8,201 | 2.50 | 20,502 |
| 2018-03-22 | Han Queena (VP Finance & HR) | Sale | 62,200 | 4.76 | 296,134 |
| 2018-03-22 | Han Queena (VP Finance & HR) | Option Ex | 62,200 | 2.50 | 155,500 |
| 2018-03-21 | Han Queena (VP Finance & HR) | Sale | 9,599 | 4.48 | 42,984 |
| 2018-03-21 | Han Queena (VP Finance & HR) | Option Ex | 9,599 | 2.50 | 23,997 |
| 2017-05-24 | Simard John (Chief Executive Officer) | Option Ex | 240,000 | .93 | 223,680 |
| 2016-11-15 | Han Queena (VP Finance & HR) | Sale | 19,573 | 15.00 | 293,595 |
| 2016-11-15 | Han Queena (VP Finance & HR) | Option Ex | 19,573 | .74 | 14,484 |
| 2016-09-08 | Han Queena (VP Finance & HR) | Sale | 427 | 15.00 | 6,405 |
| 2016-09-08 | Han Queena (VP Finance & HR) | Option Ex | 427 | .77 | 328 |
| 2016-05-26 | Mckenzie W Thorpe (Director) | Buy | 20,000 | 13.96 | 279,120 |
| 2016-05-20 | Mckenzie W Thorpe (Director) | Buy | 1,500 | 13.75 | 20,619 |
| 2015-12-22 | Han Queena (VP Finance / HR) | Sale | 10,000 | 10.27 | 102,739 |
| 2015-12-22 | Han Queena (VP Finance / HR) | Option Ex | 10,000 | .72 | 7,200 |
| 2015-12-21 | Han Queena (VP Finance / HR) | Sale | 10,000 | 10.38 | 103,750 |
| 2015-12-21 | Han Queena (VP Finance / HR) | Option Ex | 10,000 | .72 | 7,200 |
| 2015-12-18 | Han Queena (VP Finance / HR) | Sale | 10,000 | 10.78 | 107,820 |
| 2015-12-18 | Han Queena (VP Finance / HR) | Option Ex | 10,000 | .72 | 7,200 |
| 2015-11-16 | Stecher Michael (Medical Director) | Sale | 1,800 | 14.00 | 25,200 |
| 2015-11-16 | Stecher Michael (Medical Director) | Option Ex | 1,800 | 5.00 | 9,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of XBIT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xbiotech Inc. (symbol XBIT, CIK number 1626878) see the Securities and Exchange Commission (SEC) website.